A Phase I Trial of Gemcitabine Administered as a 96-h Continuous Intravenous Infusion in Patients with Advanced Carcinoma and Lymphoma
Year: 2006
Type: article
Study design: Clinical Trial
Source: Medical Oncology
DOI: 10.1385/mo:23:3:369
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W1978928249
